Details for Patent: 7,682,634
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Which drugs does patent 7,682,634 protect, and when does it expire?
Patent 7,682,634 protects EMBEDA and is included in one NDA.
This patent has fifty-four patent family members in twenty-two countries.
Summary for Patent: 7,682,634
Title: | Pharmaceutical compositions |
Abstract: | Provided herein is a pharmaceutical composition comprising an antagonist, an agonist, a seal coat, and a sequestering polymer, wherein the antagonist, agonist, seal coat and at least one sequestering polymer are all components of a single unit, and wherein the seal coat forms a layer physically separating the antagonist from the agonist from one another. Methods for manufacturing such a pharmaceutical composition are also provided. |
Inventor(s): | Matthews; Frank (Edison, NJ), Boehm; Garth (Westfield, NJ), Tang; Lijuan (Flemington, NJ), Liang; Alfred (Edison, NJ) |
Assignee: | Alpharma Pharmaceuticals, LLC (Bridgewater, NJ) |
Application Number: | 12/399,923 |
Patent Claim Types: see list of patent claims | Composition; Formulation; |
Drugs Protected by US Patent 7,682,634
International Family Members for US Patent 7,682,634
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 552829 | See Plans and Pricing | |||
Australia | 2007261451 | See Plans and Pricing | |||
Australia | 2013257508 | See Plans and Pricing | |||
Australia | 2016238844 | See Plans and Pricing | |||
Australia | 2018201915 | See Plans and Pricing | |||
Brazil | PI0714039 | See Plans and Pricing | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |